Drug Research
Tevogen Bio, BioCentriq Partner for COVID T-cell Therapy
Tevogen Bio has entered a partnership with BioCentriq, a New Jersey based cell and gene therapy development and manufacturing center, to support clinical manufacturing of Tevogen’s investigational COVID-19 treatment.
Both partners will collaborate at BioCentriq’s state-of-the art GMP facilities to...
Drug Research
Insilicos Chemistry42 AI system integrated into UCBs drug discovery programs
Insilico Medicine, an AI drug discovery company, announced that UCB will integrate Insilico's Chemistry42™ into UCB's internal drug discovery pipeline. UCB's early adoption of Insilico Medicine's proprietary technology will provide UCB's scientists with the ability to design novel hit...
Drug Research
PsiVac and Lonza Enter a Strategic Agreement for the Process Development and cGMP Manufacturing of Ixovex-1
PsiVac, a subsidiary of Ixogen; a UK biotechnology research and development company focused on the development of new therapeutic cancer treatments for solid tumors, and Lonza, a world leader in contract manufacturing, announced their agreement for the process development...
Drug Research
Moderna Announces Supply Agreement to Provide 13 Million Doses of COVID-19 Vaccine Moderna to the Philippines
Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced a supply agreement with the Government of The Philippines for 13 million doses of the COVID-19 Vaccine Moderna.
Under the terms of this agreement, deliveries would begin...
Drug Research
AGC Biologics Announces the Expansion of Their Cell and Gene Therapy Facility in Milan, Italy
AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), announced plans for the expansion of their Cell and Gene Therapy Center of Excellence in Milan, to increase capacities and implement viral vector suspension capabilities.
With this expansion,...
Drug Research
CureVac and Novartis Sign Initial Agreement on Manufacturing of COVID-19 Vaccine Candidate, CVnCoV
CureVac N.V., a global biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA), and Novartis AG announced that they have signed an initial agreement for the manufacturing of CureVac’s COVID-19 vaccine candidate, CVnCoV....
Drug Research
Clinerion and Medexprim join forces to combine clinical and imaging data for research
Clinerion and Medexprim have concluded a three-year partnership dedicated to the merger of electronic health records and imaging data into a private clinical data cloud warehouse dedicated to research.
Clinerion is the worldwide leader in medical data informatics, radically improving...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
